Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 542,000 | 713,000 | 966,000 | 761,989 | 597,550 |
| Marketable Securities | 902,000 | 749,000 | 327,400 | 550,882 | 582,501 |
| Receivables | 710,000 | 660,000 | 649,600 | 676,837 | 609,297 |
| Inventories | 410,000 | 396,000 | 374,700 | 363,058 | 329,847 |
| TOTAL | $2,789,000 | $2,733,000 | $2,578,200 | $2,594,534 | $2,361,209 |
| Non-Current Assets | |||||
| PPE Net | 1,233,000 | 1,138,000 | 1,035,600 | 931,060 | 825,301 |
| Intangibles | 9,149,000 | 9,260,000 | 9,340,500 | 9,505,170 | 9,585,206 |
| Other Non-Current Assets | 318,000 | 304,000 | 299,000 | 262,700 | 257,633 |
| TOTAL | $10,700,000 | $10,702,000 | $10,675,100 | $10,698,930 | $10,668,140 |
| Total Assets | $13,489,000 | $13,435,000 | $13,253,300 | $13,293,460 | $13,029,350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 167,000 | 167,000 | 167,000 | 322,942 | 79,136 |
| Accounts payable and accrued liabilities | 51,000 | 61,000 | 64,100 | 44,849 | 28,978 |
| Accrued Expenses | 562,000 | 546,000 | 508,000 | 485,234 | 407,289 |
| Other current liabilities | 37,000 | 47,000 | 47,200 | 117,914 | 89,637 |
| TOTAL | $856,000 | $837,000 | $822,900 | $1,034,341 | $658,462 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,804,000 | 2,846,000 | 2,888,100 | 2,929,384 | 3,171,092 |
| Deferred Revenues | 14,000 | 16,000 | 36,600 | 63,402 | 53,422 |
| aiOther Non-Current Liabilities | 290,000 | 242,000 | 219,600 | 257,398 | 233,941 |
| TOTAL | $3,758,000 | $3,742,000 | $3,736,600 | $3,755,018 | $4,171,546 |
| Total Liabilities | $4,614,000 | $4,579,000 | $4,559,500 | $4,789,359 | $4,830,008 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 223,185 | 224,557 | 224,614 | 223,931 | 224,248 |
| Common Shares | N/A | N/A | N/A | 23 | 23 |
| Retained earnings | 2,134,000 | 1,969,000 | 1,817,600 | 1,724,809 | 1,387,504 |
| Other shareholders' equity | -14,000 | 36,000 | 60,200 | -16,252 | 380 |
| TOTAL | $8,875,000 | $8,856,000 | $8,693,800 | $8,504,103 | $8,199,339 |
| Total Liabilities And Equity | $13,489,000 | $13,435,000 | $13,253,300 | $13,293,462 | $13,029,347 |